Calendar Shield Therapeutics plc

Equities

STX

GB00BYV81293

Market Closed - London S.E. 11:35:20 2024-04-23 am EDT 5-day change 1st Jan Change
1.425 GBX 0.00% Intraday chart for Shield Therapeutics plc -6.56% -78.73%

Chart calendar Shield Therapeutics plc

8e1078446f873ff6b4e125.lWhxJUl-qDnq8FdMMvMqCWFdOwYvZc37brv7TPWfHQA.xRg7HRgwnnKttzgEX8JSfA4aeH5XL4OvF4mZDrrMUlHaDjVGKkyFQNO2Yw~c1ad4361341a669bec42d5dbfd10d2b4

Upcoming events on Shield Therapeutics plc

2024-04-30 02:00 am Q4 2023 Earnings Release
2024-04-30 09:30 am Q4 2023 Earnings Call
2024-08-06 Q2 2024 Earnings Release (Projected)
2025-04-23 Q4 2024 Earnings Release (Projected)
2025-08-05 Q2 2025 Earnings Release (Projected)
2026-04-22 Q4 2025 Earnings Release (Projected)

Past events on Shield Therapeutics plc

2024-02-22 09:00 am Q4 2023 Sales and Revenue Call - Trading Update
2024-02-21 02:00 am Q4 2023 Sales and Revenue Release - Trading Update
2023-10-30 11:45 am Women’s Healthcare Conference
2023-09-28 11:30 am Q2 2023 Earnings Call
2023-09-28 02:00 am Q2 2023 Earnings Release
2023-09-11 H.C. Wainwright Global Investment Conference
2023-06-28 09:00 am Annual General Meeting
2023-04-27 11:30 am Q4 2022 Earnings Call
2023-04-27 02:00 am Q4 2022 Earnings Release
2023-02-09 02:00 am Q4 2022 Sales and Revenue Release - Trading Update
2023-01-05 09:00 am Shareholders Meeting
2022-12-14 11:30 am Investor Meeting
2022-10-25 10:00 am American College of Gastroenterology Scientific Meeting - Poster No - D0361
2022-09-08 11:30 am Interim 2022 Earnings Call - Investor
2022-09-08 09:00 am Interim 2022 Earnings Call - Analyst
2022-09-08 02:00 am Interim 2022 Earnings Release
2022-07-27 10:00 am Shareholders Meeting
2022-07-27 09:00 am Annual General Meeting
2022-06-30 11:30 am FY 2021 Earnings Call - Investor
2022-06-30 08:30 am FY 2021 Earnings Call - Analyst

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million GBP
Released
Forecast
Spread
11,9
11,9
-0.45%
0,72
1,23
-41.71%
10,4
9,40
10.46%
1,52
2,01
-24.51%
4,47
7,50
-40.48%

14,2

EBITDA
Million GBP
Released
Forecast
Spread
-2,81
-3,60
21.83%
-6,41
-6,72
4.57%
0,55
0,34
61.39%
-17,7
-18,7
5.03%
-23,3
-17,7
-31.55%

-22,9

EBIT
Million GBP
Released
Forecast
Spread
-5,17
-4,96
-4.1%
-9,04
-8,53
-5.98%
-2,15
-1,62
-32.62%
-20,0
-20,9
4.45%
-25,7
-19,4
-32.6%

-23,3

Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread
-5,15
-5,87
12.23%
-9,07
-10,2
11.51%
-1,89
-2,24
15.77%
-19,6
-21,2
7.9%
-40,1
-19,6
-104.44%

-24,8

Net income
Million GBP
Released
Forecast
Spread
-1,79
-2,59
30.61%
-8,80
-7,23
-21.71%
-2,63
-1,53
-71.5%
-19,3
-21,4
9.72%
-40,4
-19,9
-103.42%

-25,2

EPS
GBP
Released
Forecast
Spread
-0,02
-0,02
13.42%
-0,08
-0,06
-29.03%
-0,02
-0,01
-75.9%
-0,09
-0,11
16.29%
-0,17
-0,09
-95.97%

-0,04

Announcement Date03/04/1921/05/2029/04/2130/06/2227/04/23-

Quarterly results

Fiscal PeriodDecember 2020 S1 2022 S1 2023 S1
Net sales
Million GBP
Released
Forecast
Spread
8,92
0,30
2873%
2,03
1,75
16.06%
4,33
2,70
60.52%
EBIT
Million GBP
Released
Forecast
Spread



-11,7
-12,2
3.9%
-11,5
-15,0
23.06%
Announcement Date16/09/2008/09/2228/09/23

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. STX Stock
  4. Calendar Shield Therapeutics plc